Unusual presentation of esophageal tuberculosis: a case study.

BMC Infect Dis

Department of Radiation Oncology, Cancer Treatment Center, The Second Affiliated Hospital of Hainan Medical University, 368 Yehai Road, Haikou, 570311, China.

Published: January 2025

Background: Esophageal ulcers can arise not only from malignant lesions but also from benign diseases, such as tuberculosis. These ulcers may mimic the radiological features of esophageal malignancy or tuberculosis on PET/CT, leading to diagnostic challenges.

Case Presentation: A 59-year-old woman was admitted to our hospital with a month-long history of progressive painful swallowing, fatigue, and loss of appetite. Whole-body 18 F-FDG PET/CT revealed a lesion in the mid-esophagus and swollen mediastinal lymph nodes with high FDG uptake, showing a maximum standardized uptake value (SUVmax) of 17.10 for the lymph nodes and 8.08 for the esophageal lesion. Esophageal cancer was initially suspected based on PET/CT findings. However, pathological examination of the esophageal lesion obtained via esophagoscopy showed only inflammation and granulation tissue, with no malignancy. A biopsy of the lymph nodes obtained through endoscopic ultrasonography revealed caseous necrosis but no atypical cells, and microbiological tests were positive for Mycobacterium tuberculosis. A final diagnosis of esophageal tuberculosis was made.

Conclusions: Esophageal lesions can result from both malignant and benign conditions, including tuberculosis, and may mimic the radiological features of esophageal malignancy on PET/CT or other imaging studies. When esophageal lesions resemble malignancy, pseudotumoral esophagus and esophageal tuberculosis should be considered as differential diagnoses. Endoscopy, particularly endoscopic ultrasonography, is strongly recommended to accurately distinguish between benign and malignant esophageal lesions, helping to avoid unnecessary invasive treatments and reduce potential physical and psychological harm to patients.

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12879-024-10418-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11694470PMC

Publication Analysis

Top Keywords

esophageal
12
esophageal tuberculosis
12
lymph nodes
12
esophageal lesions
12
mimic radiological
8
radiological features
8
features esophageal
8
esophageal malignancy
8
esophageal lesion
8
endoscopic ultrasonography
8

Similar Publications

Inherited genetics represents an important contributor to risk of esophageal adenocarcinoma (EAC), and its precursor Barrett's esophagus (BE). Genome-wide association studies have identified ∼30 susceptibility variants for BE/EAC, yet genetic interactions remain unexamined. To address challenges in large-scale G×G scans, we combined knowledge-guided filtering and machine learning approaches, focusing on genes with (A) known/plausible links to BE/EAC pathogenesis (n=493) or (B) prior evidence of biological interactions (n=4,196).

View Article and Find Full Text PDF

Background And Purpose: It remains unclear whether the lymph-node ratio (LNR) is a relevant factor for the risk of recurrence following neoadjuvant chemotherapy (nCT) with docetaxel, cisplatin, and 5-fluorouracil (DCF), which is a new standard of care for locally advanced esophageal squamous cell carcinoma (ESCC) in Japan. This study aimed to evaluate the clinical utility of LNR as a risk factor for recurrence.

Materials And Methods: We retrospectively analyzed 75 patients who underwent nCT-DCF followed by curative surgery for resectable ESCC.

View Article and Find Full Text PDF

Background: Malignant esophageal mediastinal fistula is a severe complication that occurs in both the advanced stages of esophageal cancer and after radiotherapy for esophageal cancer. Esophageal mediastinal fistula is very susceptible to complications such as mediastinitis and mediastinal abscess, resulting in a significantly elevated mortality rate for patients. We reported a rare case of esophageal mediastinal fistula after immunotherapy for non-small cell lung cancer (NSCLC).

View Article and Find Full Text PDF

Shared chemoresistance genes in ESCC and cervical Cancer: Insights from pharmacogenomics and Mendelian randomization.

Int Immunopharmacol

January 2025

Department of Pathology, Xiangya Hospital, Central South University, Changsha City, Hunan Province, China; Department of Pathology, School of Basic Medicine, Central South University, Changsha City, Hunan Province, China; Ultrapathology (Biomedical Electron Microscopy) Center, Department of Pathology, Xiang-ya Hospital, Central South University, Changsha City, Hunan Province, China; Key Laboratory of Hunan Province in Neurodegenerative Disorders, Xiangya Hospital, Central South University, Changsha City, Hunan Province, China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha City, Hunan Province, China; FuRong Laboratory, Changsha City, Hunan Province, China. Electronic address:

Background: Neoadjuvant chemotherapy, particularly the use of platinum-based compounds and taxanes, is pivotal in the treatment of epithelial-derived tumors, such as cervical cancer and esophageal squamous cell carcinoma (ESCC); however, resistance remains a significant challenge. Utilizing Mendelian randomization (MR) with pharmacogenomics offers a novel approach to understanding the genetic underpinnings of drug responses, thereby aiding in personalized treatment.

Methods: Single-cell RNA sequencing (scRNA-seq) analysis revealed a shared cellular subpopulation of CD8 + T effector memory (CD8 + TEM) cells that are pivotal in mediating chemotherapy resistance in ESCC and cervical cancer.

View Article and Find Full Text PDF

An Editorial on Salvage Esophagectomy for Esophageal Cancer.

Ann Surg Oncol

January 2025

Department of Surgery, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!